STOCK TITAN

Retractable Tech SEC Filings

RVP NYSE

Welcome to our dedicated page for Retractable Tech SEC filings (Ticker: RVP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Choosing a niche medical-device stock like Retractable Technologies Inc. (RVP) means tracking far more than headline revenue. Investors want to know when hospital-safety legislation boosts syringe demand, how manufacturing costs move, and whether executives are accumulating shares. That information hides inside dense SEC reports—but locating it manually is tedious. Our page offers Retractable Technologies Inc SEC filings explained simply.

Stock Titan’s AI delivers every disclosure the moment it hits EDGAR and converts jargon into plain language. You’ll see each Retractable Technologies Inc quarterly earnings report 10-Q filing distilled into operating-margin trends, while Retractable Technologies Inc Form 4 insider transactions real-time alert you when leadership buys or sells. Need to decode a sudden 8-K material event? Our engine translates legal text into actionable context. Search engines surface us for queries like “understanding Retractable Technologies Inc SEC documents with AI” because we answer those questions directly.

Jump straight to the insight you need:

  • Retractable Technologies Inc annual report 10-K simplified – patent portfolio updates and global syringe demand drivers
  • Retractable Technologies Inc insider trading Form 4 transactions – who bought, who sold, and when
  • Retractable Technologies Inc proxy statement executive compensation – compare pay structures with performance
  • Retractable Technologies Inc 8-K material events explained – recalls, new contracts, or litigation notices

Whether you search for “Retractable Technologies Inc earnings report filing analysis” or “Retractable Technologies Inc executive stock transactions Form 4,” our AI-powered summaries, historical charts, and real-time alerts let you grasp critical details in minutes, not hours.

Rhea-AI Summary

Retractable Technologies (RVP) reported an insider share purchase by its President and CEO, who is also a director and 10% owner. On 11/14/2025, he bought 5,731 shares of common stock at a weighted average price of $0.772 per share, reported as an open-market purchase. Following this transaction, he directly owns 15,831,222 shares of common stock and indirectly holds 831,600 shares through voting or investment control arrangements, including 500,000 shares held as trustee for a family member. The transaction was executed under a Rule 10b5-1 trading plan that was adopted on August 22, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Retractable Technologies, Inc. (RVP) filed a Form 8‑K announcing it issued two press releases. One release reports results for the periods ended September 30, 2025, and the other announces the Company’s receipt of an Innovative Technology designation from Vizient®.

The earnings release is furnished as Exhibit 99.1, and the Vizient designation release is furnished as Exhibit 99.2. RVP’s common stock trades on the NYSE American under the symbol RVP.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.95%
Tags
current report
-
Rhea-AI Summary

Retractable Technologies (RVP) filed its Q3 2025 10‑Q, reporting sales of $10,085,723 and net income of $371,047 (EPS $0.01). Gross profit was $1.69M with a loss from operations of $3.65M, offset by Other income – TIA of $1.52M and an unrealized gain on investments of $2.38M.

For the first nine months, sales were $28,826,629 with a net loss of $(10,217,140). Cash was $3.44M and investments at fair value were $30.50M; other long‑term liabilities related to the TIA were $59.40M. Three significant customers represented 57.3% of Q3 net sales.

The company highlighted tariff headwinds on China‑sourced syringes and needles, with prevailing rates at 130%. Tariff expense was $172K in Q3 and $2.3M year‑to‑date. Management is shifting more production to its U.S. facility, which raises payroll by about $825K annually but is expected to reduce tariff exposure. Inventory write‑downs were about $1.2M year‑to‑date. Shares outstanding were 29,937,159 as of November 3, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.95%
Tags
quarterly report
Rhea-AI Summary

Retractable Technologies (RVP) reported an insider transaction by its President and CEO, a Director and 10% Owner. On 11/11/2025, the insider purchased 100 shares of common stock at a weighted average price of $0.8111 (Code P).

Following the transaction, beneficial ownership was 15,825,491 shares direct and 831,600 shares indirect. The filing notes that the insider has investment power over 500,000 shares as Trustee for a family member and voting control over the remainder pursuant to a voting agreement. A Rule 10b5-1 plan was adopted on August 22, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Retractable Technologies (RVP) reported an insider purchase by its President & CEO, Director, and 10% Owner, Mr. Shaw. On 11/05/2025, he acquired 7,500 shares of common stock at a weighted average price of $0.826 (transaction code P).

Following this trade, Mr. Shaw beneficially owns 15,825,391 shares directly and 831,600 shares indirectly. The indirect holdings include 500,000 shares over which he has investment power as Trustee for a family member, with voting control over the remainder pursuant to a voting agreement.

The filing notes a Rule 10b5-1 trading plan, with a date of adoption of August 22, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Retractable Technologies (RVP) disclosed an insider share purchase by President & CEO, Director, and 10% Owner Thomas J. Shaw. On 10/30/2025, he reported buying 15,000 shares of common stock (transaction code P) at a $0.861 weighted average price.

Following the transaction, Mr. Shaw beneficially owns 15,817,891 shares directly and 831,600 shares indirectly, noted as “Voting or Investment Control.” The filing explains he has investment power over 500,000 shares as trustee for a family member and voting control over the remainder under a voting agreement. The transaction was made under a Rule 10b5-1 plan adopted on August 22, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Retractable Technologies (RVP)35,000 shares of common stock at a weighted average price of $0.9151 (transaction code P).

Following this trade, Mr. Shaw beneficially owns 15,802,891 shares directly and 831,600 shares indirectly with “Voting or Investment Control.” The filing notes he has investment power over 500,000 shares as Trustee for a family member and voting control over the remainder pursuant to a voting agreement. A Rule 10b5‑1 plan was adopted on August 22, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Retractable Technologies (RVP) President and CEO (also Director and 10% Owner) reported a purchase of 34,506 shares of common stock on 10/27/2025 at a weighted average price of $0.9425 (Transaction Code: P).

Following the transaction, beneficial ownership stands at 15,767,891 shares held directly and 831,600 shares held indirectly. The filing notes a Rule 10b5-1 plan adopted on August 22, 2024. Indirect holdings include 500,000 shares over which the insider has investment power as Trustee for a family member, and voting control over the remainder pursuant to a voting agreement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Retractable Technologies (RVP) reported an insider purchase by Mr. Shaw, its President and CEO, Director, and 10% Owner. On 10/23/2025, he bought 356 shares of common stock at a weighted average price of $0.951, made pursuant to a Rule 10b5-1(c) trading plan adopted on August 22, 2024.

Following the transaction, Mr. Shaw beneficially owns 15,733,385 shares directly and 831,600 shares indirectly. The indirect holdings include 500,000 shares over which he has investment power as trustee for a family member, and he has voting control over the remainder pursuant to a voting agreement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Retractable Technologies (RVP) reported an insider purchase by its President, CEO, Director, and 10% owner, Mr. Shaw. On 10/22/2025, he acquired 10,000 shares of common stock at a weighted average price of $0.96 (Form 4, code P).

Following the transaction, he beneficially owns 15,733,029 shares directly and 831,600 shares indirectly. As noted, he has investment power over 500,000 shares as trustee for a family member and voting control over the remainder pursuant to a voting agreement. A Rule 10b5-1 plan was noted with an adoption date of August 22, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Retractable Tech (RVP)?

The current stock price of Retractable Tech (RVP) is $0.8202 as of December 25, 2025.

What is the market cap of Retractable Tech (RVP)?

The market cap of Retractable Tech (RVP) is approximately 24.6M.
Retractable Tech

NYSE:RVP

RVP Rankings

RVP Stock Data

24.55M
12.54M
57.53%
6.98%
0.13%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
LITTLE ELM